0001555280-25-000144.txt : 20250221 0001555280-25-000144.hdr.sgml : 20250221 20250221172036 ACCESSION NUMBER: 0001555280-25-000144 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250219 FILED AS OF DATE: 20250221 DATE AS OF CHANGE: 20250221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PECK KRISTIN C CENTRAL INDEX KEY: 0001488267 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 25653271 MAIL ADDRESS: STREET 1: C/O ZOETIS INC. STREET 2: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wk-form4_1740176430.xml FORM 4 X0508 4 2025-02-19 0 0001555280 Zoetis Inc. ZTS 0001488267 PECK KRISTIN C C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 1 1 0 0 Chief Executive Officer 0 Restricted Stock Unit 2025-02-19 4 A 0 21745 0 A Common Stock 21745 21745 D Restricted Stock Unit Common Stock 10951 10951 D Restricted Stock Unit Common Stock 6135 6135 D Stock Option 156.64 2025-02-19 4 A 0 84711 0 A Common Stock 84711 84711 D Stock Option 196.14 Common Stock 62500 62500 D Stock Option 162.07 Common Stock 67148 67148 D Stock Option Common Stock 269632 269632 D Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Not applicable. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 8, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025. Each option expires on the tenth anniversary of the date of grant. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 8, 2023. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. 20,000 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14,2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option. Each option vests on the third anniversary of the date of grant. /s/ Brenda Santuccio, as Attorney-in-Fact 2025-02-21